In a significant move, hospitals in New York City have decided to sever ties with the controversial AI firm Palantir. This decision comes as Palantir is actively expanding its operations in the UK, where it aims to enhance its foothold in the healthcare sector. Critics of Palantir have raised concerns over privacy and ethical implications surrounding its technology, prompting these hospitals to reevaluate their partnerships. As Palantir continues to navigate the complex landscape of AI in healthcare, its growth in the UK may serve as a pivotal moment in the company's journey, while New York institutions seek alternatives that align better with their values and the welfare of patients.